Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Adicionar filtros








Intervalo de ano
1.
Braz. j. infect. dis ; 19(1): 36-42, Jan-Feb/2015. graf
Artigo em Inglês | LILACS | ID: lil-741244

RESUMO

Background: Visceral leishmaniasis (VL) or Kala-Azar (KA) is one of the most deadly forms of disease among all neglected tropical diseases. There are no satisfactory drugs or vaccine candidates available for this dreaded disease. Our previous studies showed promising therapeutic and prophylactic efficacy of the live, radio-attenuated parasites through intramuscular (I.M.) and intraperitoneal (I.P.) route in BALB/c mice model. Methods: The T-cell proliferation level, the mRNA expression level of inducible nitric oxide synthase (iNOS) and tumor growth factor-beta (TGF-β) genes and finally the phosphorylation levels of phosphoinositide dependent kinase 1 (PDK1), phosphoinositide 3 kinase (PI3K) and p38 mitogen activated protein kinase (p38MAPK) molecules were checked in BALB/c mice model immunized with radio-attenuated Leishmania donovani parasites through I.M. route. Results: Higher T-cell proliferation, increased iNOS level, and suppressed TGF-β level were found in treated infected animal groups (100 and 150 Gy) in relation to untreated infected animals. Likewise, phosphorylation levels of PDK1, PI3K and p38MAPK of these two groups were increased when compared to untreated infected controls. Conclusion: The clearance of the parasites from treated infected groups of animals may be mediated by the restoration of T-cell due to therapy with radio-attenuated L. donovani parasites. The killing of parasites was mediated by increase in nitric oxide release through PDK1, PI3K and p38MAPK signaling pathways. A lower TGF-β expression has augmented the restored Th1 ambience in the 100 and 150 Gy treated animal groups proving further the efficacy of the candidate vaccine. .


Assuntos
Animais , Feminino , Masculino , Vacinas contra Leishmaniose/imunologia , Leishmaniose Visceral/imunologia , /genética , Western Blotting , Proliferação de Células , Modelos Animais de Doenças , Perfilação da Expressão Gênica , Injeções Intramusculares , Injeções Intraperitoneais , Vacinas contra Leishmaniose/administração & dosagem , Leishmaniose Visceral/prevenção & controle , Camundongos Endogâmicos BALB C , Óxido Nítrico Sintase Tipo II/genética , Carga Parasitária , Fosforilação , RNA Mensageiro , Células Th1/imunologia , Fator de Crescimento Transformador beta/genética , Vacinas Atenuadas/administração & dosagem , Vacinas Atenuadas/imunologia , /genética
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA